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Illuminated partly by the green light ofa laser, Medical Scientist Training Program student
Patrick Jay measures the diffusion of membrane proteins on the surface of a cell using
1'1 uorescence photobleaching recovcry (FPR). A spot on the cell, which has a specific population
of its membrane proteins labeled with a tluorescent marker. is illuminated with a laser beam.
The tluorescence in the spot is thcn climinated photobleached with an intense pulse of laser
light. Thc l1uorescence recovers as labeled protein molecules from nearby diffuse into thc
bleached spot. The rate of tluorescence recovery corresponds to the rate of rrotein diffusion.
FPR has been used to study the behavior of ion channels and receptors that are important in
synapse formation. The FPR apparatus is in the lab of Elliot Elson, Ph.D., professor of
biochemistry and molecular biophysics.
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A Promising Alternative
Us ing stri c t bioco mpatibility as the ir keysto ne ,
phys icia ns produce a ne w breas t impl a nllh at does
not inte rfere with mammography.

The Clinical Connection

Mo re than just the "b lues,"
de pressio n affec ts eat in g, s leeping
and th e ab i lity to fu nc ti on.
Ne uro logis ts, psyc hi atri sts and
radio logists are coll abo rati ng to
trace the ne ura l circui ts th at o pe rate
in the pe rsiste nt fee lings of fa ilure ,
loss, guilt and death that c harac te ri ze
the d isease. T he photographi c
re presentatio n of de pression is by
To m Hei ne.
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A fler a major contribut ion to c linical med ic ine, a
be nc h-sc ie nce team re turn s to stud y bas ic qu esti o ns.
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Cell In.i tI"'~
new center is being
established to develop
strategIes to protect
the brain and spinal cord from
injury due to disease or trau
ma and to promote recovery
after injury has occuned.
The center - known as
the Center for the Study of

A

Dennis W. Choi, M.D., Ph. D.

2

Nervous System Injury at
Washington University School
of Medicine - is the result
of an $8 million, five-year
collaborative agreement be
tween the university and
Hoffmann-La Roche Inc. , in
Nutley, N.J. Denni s W. Choi,
M.D., Ph.D., professor and

head of the medical school's
neurology department , will
serve as the center' s director.
'This alliance presents a
remarkable opportunity for a
pharmaceutical company and
an academic institution to make
use of their similar interests
and different strengths \0 ad
vance the understanding of
neurological diseases and to
generate new , more effective
treatments," says William A.
Pec k, M.D., vice chancellor
for medical affairs and dean
of the School of Medicine.
Under the terms of the
agreement , Hoffmann-La
Roche will contri bute $1 .6
million for each of the next
five years to support tile cen
ter. In addition to financial
support, Hoffmann-La Roche
will provide technical exper
ti se and patent law services
and also may develop phar
maceutical products which
result from the collaboration .
According to Choi, sc ien
tist s working in the center
will focus on preventing, lim
iting and reversing damage
to cells in the brain or spinal
cord. "The center is taking a
somewhat untraditional
approach," Choi explain s.
"Researchers hoping to
develop new therapeutic
approaches usually target a
spec ific illness, such as
Alzheimer's disease or stroke.
By studying the problem of
nerve cell injury across di s
ease boundaries, we hope to
learn enough about underlying
common principles to devise
new therapies." •

I)rug Bloeks
Spl'(~ad ()fFlu
Vi ru!oi
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espite concerted
effort, diseases
attributed to viruses
have remained much more
difficult for medical sc ience
to treat than those caused by
bacteria. But recently, a team
of researchers herc developed
a compound that in laborato
ry tests is 95 perce nt effec ti ve
at blocking the spread of one
strain of inf1uenza virus. It is
a glimmer of hope for the
future.
Thc compound is a pep
tide (a small chain of amino
acids) which stops the influen
za virus from spreading by
disabling the Velcro-like
spikes the viru s uses to grab
hold of and infect a healthy
cell. says Milton 1. Schlesinger,
Ph.D., professor of molecular
microbiology.
Although the peptide may
be years away from clinical
application , Schlesinger says
this approach may provide a
basic plan of attack against
many viruses including rabies,
hcrpe s and respiratory sy ncy
tial viru s (RSV), a virus
harmful to infants. Schlesinger
reports in a recent issue of
Vir(llogy that the peptide in
hibits formation of influenza
virus in infected cultured cells.
With the flu epidemic a
lingering memory in many
parts of the United States,
attempts to find effec ti ve
agents other than vaccines to
block the virus' spread have
been increased. That isn't
likely to happen, Schlesinge r

-T
says , because decades of
resea rch on viru ses have led
to a relati vely small arma
mentarium compared to the
wealth of antibiotics that bac
terial researc h has produced.
The difficulty lies in
designing a drug that kill s
viruses without injuring their
host cells. Because most
viruses contain a small num
ber of genes, they comm an
deer many gene products
required for their replication
from the host cell. Consequent
ly, drugs aimed at viruses
also may s top normal cellular
function s, Schlesinger says.
Engineering a drug that
kill s the virus without killing
its host is an arduous task.
However, the mol ec ule
Schlesinger designed does just
that. The peptide blocks the
attachment of the Velcro-like
spikes to the flu virus. Without
its spikes, the virus can't get
into a cell, Schlesinger says.
Normally , eac h spike is
anchored to a "pocket" inside
the virus. The molecules that
Schlesinger and his collabora
tors study are believed to fit
into this pocket, preve nting
the spikes from anchoring."lf
the pocket is filled, new virus
es will no longer appear, and
that will be the end of the
infection ," Schlesinger says.
Further studies are needed
to determine the effectiveness
of the approach. Schlesinger
recently received a four-year ,
$800,000 grant from th e
National In stitutes of H ea lth
which will fund the d esig n of
sma ller, more pote nt mole
cules to stop a variety of
viruses. The initial research
was partially funded by
Monsa nto-Searle. •

Biol-'ta t isti.·s
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A

s part of the celebra
tion of 25 years of
dedication to educa
tion, research and cons).lita
tion fo r the medical school
community, the division of
biostatistic s hosted a work
shop on study design and
brought fi ve distingui shed
speakers to campus from
around the world late in 1991.
The workshop , aimed at
investigators at th e medical
school currently contemplat
ing submi ssion of a clinical
research proposal, dealt with
the practical and scienti fic
iss ues of designing the study
and strategies for writing a
successful proposal.

.Ill bi I(~p

The speaker series brought
to campus Newton E. Mo rton ,
Ph. D., director of the CRC
Research Group in Genetic
Epidemiology, Southampton
General Hospital , Southamp
ton , England; Paul Meier,
Ph.D. , Ralph and Mary Oti s
Professor of Statistics, Univer
sity of Chicago; Charl es F
Sing, Ph.D., professor of
genetics, University of Michi
gan, Ann Arbor; William B.
Kannel , M.D. , M.P.H., profes
sor of medic ine, Boston Uni
versity Sc hoo l of Medicine,
and C.R. Rao, Ph.D., holder of
the Eberly Chair in the Depart
ment of Statistics at Pennsyl
vania State University.

The speakers addressed
the frontiers and challenges
facing researchers in bio
statistics and genetic epidemi
ology.
Speaking about the role of
genetic variation in coronary
artery disease, Sing told his
audience that the initiation,
progression and severity of
the disease are determined by
anatomical , biochemical and
physiological traits that are
each like ly to be influenced
by several genetic and envi
ronmental causes. Yet most
genetic resea rch has concen
trated solely on the metaboli sm
of cholesterol, with the res ult
that the true role genetic vari
ation plays in predi spos ing to
coronary artery di sease is
underestimated . •

Cryer l\anU:lo(l Editor"
a

hilip E. Cryer, M.D. ,
director of the divis ion
of endocrinology, dia
betes and metabolism, has
been named editor of the lead
ing diabetes resea rc h publica
tion, Diabetes. He assumed
duties January 1.
Cryer, professor of medi
cine , is on staff at Barn es
Hos pital, and is a consulting
phys ician at Jewi sh and St.
Louis Children's hospitals,
all part of W as hington Uni
versity M edi c al Center.
Six other School of Medi 
cine faculty membe rs wi II
serv e as associate editors of
th e journal. They are: David
D. Chaplin , M .D., Ph.D.,

P

Philip E. Cryer, M.D.,
assumed the editorship of
Diabetes on January I.
assoc iate professor of medi
c ine and assistant professor
of genetics and molecular

microbiology; Michael L.
McDaniel, Ph.D., associate
professor of pathology ; Mike
M. Mueckler, Ph.D. , associ
ate professor of cell biology
and physiology; M. Alan
Permutt, M.D ., professor of
medicine; Julio V. Santiago,
M.D., professor of pediatrics
and associate professor of
medicine, and Joseph R.
Williamson, M .D., professor
of pathology .
Published by the Ameri
can Diabe tes Association
sinc e 1952, Diabetes is the
world ' s leading diabetes
related publication. LJ
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esearchers at Wash
ington University and
CytoTherapeutics, Inc.
have successfully controlled
bl ood sugar (glucose) leve ls
for ex tended period s in mi ce
by usin g a small islet cell 
co ntaining membrane im 
planted under the skin. The
researc h, reported recently in
the journal Science, demon
strate s the potential for treat
in g in sulin dependent di abetes
by implanting en capsul ated,

R

Tiny islet cell-filled mem
branes have successfully
controlled glucose levels
when placed under the skin
of laboratory animals. The
encapsulated devices are
isolated from the effects of
the immune system.

4

in sulin-producing ce ll s beneath
the sk in .
"Thi s researc h is an impor
tant step toward the de velop
ment of islet ce ll impl ants to
treat insulin dependent dia
betes," says Paul E. Lacy,
MD , Ph. D , Robe rt L Kroc
Professor of Pathology and
the lead author on the paper.
" It is particularl y e ncouraging
th at the implant functi oned as
we ll under the skin as when
pl aced in the abdome n. A
dev ice placed under the skin
is the most practical method
fo r implanting islet cells
because it can be in serted and
retri eved eas ily. The findings
also ful fill several other pre
requi sites Cor an islet encapsu
lati on device for possible use
in human diabetics, including
bi ocompatibility and preven
ti on of rejecti on."
"Encaps ul ation devices
that isola te the im planted
ce ll s from the immune sys
te m, all ow in g them to sur
vi ve and functi on without the
need for immunosuppress ive
drugs, pro vide pro mi se as a
therapeuti c approac h to di a
betes," says Lacy.
Islet cell s are loc ated in
the pancreas, where they are
res ponsible for produ c in g
and secreting insulin , a hor
mone critical for the brea k
down of glucose. In in sulin
dependent diabetes, al so
known as diabetes mellitu s,
islet cells are destroy ed. As a
result , patients mu st rece ive
dail y in sulin injecti ons to
contro l blood glu cose leve ls.

According to the America n
Diabetes Association, di a
bete s mellitu s affects more
than I million indi vidu als in
the United States .
In their work, the re
searchers suspe nded rat islets
in a gel and encapsul ated them
in hollow, semi -permea bl e
plastic fi bers. They pl aced
the device s either und er the
skin (subcutaneo usly ) or
in side the abd omen (intraper i
ton ea ll y) of diabetic mice.
The mice impl anted with the
en capsu lated rat isle ts did not
recei ve immunosuppressive
drugs. For 60 days, the implant
maintained norm al glucose
le vels in over 80 pe rce nt o f
the rec ipient animals at both
the subcut aneous or intrape ri
ton ea l sites and wi th either
500 or 1,000 islets. When the
impl ants were removed at the
end of the 60-day pe ri od, the
diabeti c co nditi on returned.
"The ability of the subcu
tan eo us impl ant to fun cti on
effec tiv ely in mice with as
few as 500 rat is lets provides
enco urag ing s upport that a
device 0 (" an acceptabl e size
can be des igned fo r human
use," says Orion Hegre, Ph.D.,
Cy toThe ra pe utics' director of
e ndocrine sc ie nce and a co
author of the stud y. " An
impl ant suit abl e for human
use is ex.pected to requ ire
abou t 500,000 islet s."
The sc ienti sts say that the
next step in their collaboration
is to des ign and test a device
for use in larger animals.
They hope to have a device
ready fo r initial human test
ing in several years . •
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orne day, Cheryl Spessert
may be to Broadway
show tunes what Richard
Simmons is to the oldies.
While Simmons and his
ove rweight followers stay fit
by groo vin' to some of rock
and ro ll 's greatest hits, Spessert
in corporates Broadway cla s
s ics into an ex ercise routin e
she has deve lo ped for peopl e
ph ys ica ll y limited by di sease.
Spessert , a pulmonary nurse
clinician. is the impetus
behind a new exercise and
educati onal videotape called
"Ch airo bics," which she says
is the first of its ki nd.
The two-hour videot ape
demonstrates ex. erci ses per
fonned in a chair and designed
for people with mod erate to
severe chronic obstructiv e
pulmonary disease. Spesse rt,
who appears in the videota pe,
had the id ea seve ra l yea rs
ago while directin g cardiopul 
monary rehabili tati on at the
Fitness and Health Institute
in Tucso n.
The fitness program is
made fun , Spessert says,
beca use the exercises are
c horeographed to fa mili ar
Broadway and cl ass ica l hit s
in c ludi ng " If I Were A Ri c h
Man," and "Hell o Do ll y." " It
makes an enormous di ffe r
ence to work out to mu sic
you know, and fo r this partic
ul ar age group, these class ic s
are some of their favo rites ,"
she says.
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hree researchers at the
Sc hool of Medi cine
ha ve been as ked to
serve on separate stud y sec 
ti ons in the Division of Re
searc h Grants for the Nati onal

To the beat ofpop classics,
pulmonary nurse clinician
Cheryl Spessert instructs
people physically limited by
disease in "Chairobics," an
exercise program that main
tains fitness and provides
pulmonary rehabilitation.
Spesse rt says the video
provides instruction on
brea thin g tec hniques and
oxyge n th era py and teache s
stret chin g, weight training, a
cardi ovasc ular workout and
relaxati on tec hniques. Man y
of the exe rcises benefit the
upper ex tremities becau se
th at's where people with
emphy se ma have difficulty
mai ntaining strength.
Spesse rt authored the
sc ript with the assistance of
Dani el M. Goodenberger,
M.D., ass istant professor of
med icine. Other consultants
were: Pam Becker Weilit z,
pulmonary nurse specialist at
Barnes Ho spital; J ill Feldman
Mal en, pulmonarylthoracic
nurse spec ialist at Barnes
Hos pital; and Cheri CarswelL
exercise physiologist and co
director of pu Imonary reha
bilitation at the Fitness and
Hea lth Institute in Tuc so n.

Lee Ratner, M.D., Ph.D.
survey the statu s of researc h
in their field s of sc ience.
Giddings, who will se rve
on the Physiologica l Sciences
Study Section, researches the
reg ulation of insulin ge ne

Stephen./. Giddings,
M.D., Ph.D.
In stitutes of Health (NIH).
Stephen J. Giddings,
M.D. , Ph.D., associate pro
fessor of medicine; Lee Rat
ner, M.D., Ph.D., assoc iate
professor of medicine and
assistant professor of molec u
lar mi crobiology , and Stanley
J. Korsme ye r, M.D ., profes
sor of medicine and assoc iat e
professor of molecular mi cro
biology, will help to rev iew
grant applications submitt ed
to the NIH , make recomm en
dati ons on the appl icati ons to
th e approp riate NIH nati onal
advisory council or board and

Ratner, who will serve on
the AIDS and Re latecl Re
search 3 Study Sec ti on, is
researching the origin and
development of hum an retro
virus infection s. Ratner is co
director of the Was hington
Uni versity AIDS Clinical
Trial s Unit and ove rsees
in vestigation of a va ri ety of
therapeutic interventions fo r
HIV infection and related
retroviruses.
Korsmeyer, asked to serve
on the Pathology B Study
Section, investi gates chromo
so mal tran s loca ti ons that lead
to various form s of le ukemi a
and lymphoma . He is an
associate in ves ti ga tor with
the Howard Hu ghes Medi ca l
Institute at the Sc hoo l of
Medicine and a member of
the American Society for
Clinical Investi gati on.
Study section members
are selected on the bas is of
their demon strated ac hi eve
ment in their scie ntifi c di sc i
pi ine as evidenced by the
quality of re search accom
plishments, publi cations in
scientific journals and other
achievements and honors.

L

Stanley./. Korsmeyer, M.D.
expression. He is assoc iate
chief of staff for research an d
development at the SI. Loui s
Veterans Admini strati on
Medical Center and is a
member of the End oc rin e
Societ y and the Ameri ca n
Societ y for Biochemi sts and
Molecular Bio log ists.

5

dding two drugs to
the standard ea rly
treatment for heart
attack s may help prevent
blockages that often recur
and inflict additional damage
in the hours following an
initial attack.
Using an animal pre para
tion, scientists here have
demonstrated that the drugs
aspirin and recombinant
hirudin can prevent the dam
aging blockage of heart ves
sels that sometimes occurs
after the initial attack-induc
ing blockages are cleared
away. Hirudin is a protein
from the saliva of leeches
produced by recombinant
DNA technology.
Hirudin and aspirin prevent
clots via two separate actions.
Hirudin inhibits an enzyme
that induces formation of the
thread-like protein, fibrin.
Fibrin entangles platelets in
masses to form clots. Aspirin
is an antiplatelet agent that
prevents blood platelets from

A

6

stic king together and con
tributing to clotting.
"Our result s support the
idea that an antithrombin
agent alone is not suffici ent,
that one will have to give an
antiplatelet agent as we ll," to
open arteries quic kly and
kee p them open, says Dana
Abe ndsc hein, Ph .D. , one of
the investigators.
The use of c lot-disso lvin g
drugs such as streptokinase
and ti ss ue-type plasm inogen
activator (t-PA) has been a
major advancement in treating
hea rt attacks, Abend sch e in
says. Admini ste red in the ear
ly hours after a heart attack,
they break lip clots that typi
cally form obstructions. By
restoring blood fl ow , they
often can preve nt substantial
irreversible damage to the
heart muscle.
But there are limitations
to this treatment, explains
Abendschein , a research asso
ciate professor of medicine.
Blood flow is not restored in
about one third or patients.
And in about 20 percent of
patients in whom flow is
"cstored, blockages return
within about 24 hours,
To avoid reblockage, clin
icians sometimes gi ve heart

attack patients aspirin and
hepari n, But neither drug has
been effective enough. "So
the search is really on for
new approaches that might be
more effecti ve than these
conventional agents," he says,
In the study, Abendshein
and co-authors Nelson Prager,
M.D. , clinical fellow in
medicine, Sheryl Torr, Ph.D.,
research instructor in medi
cine, and Burton Sobel,
M.D., professor of medicine,
induced blood clots in the
arteries of dog hearts and
mechanically narrowed the
artery to mimic a site of
atherosclerotic plaque. They
found that hirudin - already
shown in their lab to prevent
reb lockage without the pres
ence of an arti ['icial vessel
narrowing - and aspirin,
given separately with the
clot-disso lvin g dru g t-PA,
did not prevent re blockage.
But when both were given
togeth er with t-PA, the drugs
prevented re blockage . •

For heart attack victims, a
combination of drugs is
proving to be effective in
preventing the blockage of
heart vessels that sometimes
recurs after the first block
age has been cleared away,

1\1 i t ie'll
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F."ozen

T

he School of Medicine
has restructured its
tuition policy to freeze
costs throughout the four
years of medical school for
s.tudents enrolling in the
1992-93 academic year,
according to WiJliam A.
Peck, M.D., vice chancellor
for medical affairs and dean
of the School of Medicine.
For new students entering
the school in August 1992,
annual tuition wIll be $19,800
and will be frozen at that
amount for all four years of
medical education. For cur
rently enrolled students, tuition
will be increased 5 percent,
from $15,900 to $16,700.
The new tuition was
approved by the University's
Board of Trustees upon the
recommendation of the Execu
tive Faculty, a medical school
governing board composed of
the 18 department heads.
''Tuition at Washington
University School of Medi
cine has not and still will not
cover the full costs of medi
cal education , but the increase
for incoming students address
es the fac t that those costs
have ri sen much faster than
our tuition, " says W. Edwin
Dodson, M.D., associate dean
fo r admissions and financial
aid. " At the same time, we
wanted to change our tuition
structure - to in efl'ect freeze
tuition - in order to stabilize
our new st udents' expenses
and allow them to plan for all

four years of their medical
education."
The Executive Faculty has
long held the line against
sharp increases in an attempt
to limit the debt load under
taken by medical students.
Large educational debts have
been associated with young
physicians' tendencies to
select higher-paying special
ties and to avoid careers in
primary care and academic
medicine, a trend the Execu
tive Faculty would like to see
reversed. The indebtedness of

Hp~("aJ·("h("rs

Washington University medi
cal students is below the
national average.
Medical school tuition at
Washington University tradi
tionally has been considerably
lower than that charged by
schools of comparable quali
ty, such as Johns Hopkins,
Stanford, Yale, Cornell,
Columbia and Harvard. The
School of Medicine's tuition
was reduced 5 percent in
1988-89, not increased at all
in 1987-88 and increased only
3 percent in 1986-87. Increas

rl'nlf"k

ramatic new images
of the brain show that
writer's cramp
once thought to be a psychi
atric condition - can now be
traced to abnormal brain func
tion. "This is the first evidence
of physiological changes in the
brains of patients with this
mysterious disorder," says Lee
W. Tempel, M.D., research
instructor in neurology.
Tempel and Joel S.
Perlmutter, M.D., assistant
professor of neurology,
explain that people with writ
er's cramp suffer involuntary
muscle cramps in the hand or
forearm when performing
specific activities such as
writing or typing. [n severe
cases, the condition can
impair use of the hand, forc
ing those affected to learn to
write with their other hand.
People with a less severe
form of the disorder experi
ence uncomfortable cramps
while wri ti ng.

es in 1989-90, 1990-91, and
1991-92 were held in the 5
to 7-percent range. Tn recent
years, Washington Universi
ty's medical school tuition
has been well below the
national average for private
medical schools. Tn 1991-92,
for example, tuition at Wash
ington University ranked
46th out of 52 private medi
cal schools.
Unlike most other medical
schools, Washington Univer
sity School of Medicine's
tuition is all-inclusive; no

1)",,,11 ,rrih".o"s Cnunp

Because questions re
mained about the brain's role
in writer's cramp, Tempel
and Perlmutter used positron
emission tomography (PET)
to track blood flow in the
brains of people suffering
from the disorder. PET shows
changes in brain blood tlow,
which doctors interpret as a
signal of brain activity. Blood
flow abnormalities tell doctors
that there may be abnormal
brain function even though
the structure of the brai n as
seen with a CT or MRI scan
is norma I.
While in the PET scanner,
six patients from 24 to 72
years of age with right-hand
ed writer's cramp and eight
age-matched normal subjects
had a vibrator touched to
their hands. The group with
writer's cramp showed 30
percent less of an increase
in blood flow to the area of
the brain responsible for
sensing and moving the hand

Research has traced writer's
cramp to abnormal brain
function - the first evi
dence of a physiological
basis for the disorder.
(primary sensorimotor area)
and the area that prepares for
hand movement (supplemen
tary motor area).
Responses were dimin
ished on both sides of the
brain, although only one side

additional fees are assessed to
cover student health or stu
dent activities, for example.
And the school has an aggres
si ve fi nancial aid program
that meets 100 percent of the
documented financial needs
of every student who applies
for financial aid.
"The tuition increase will
help ensure that we remain
at the forefront of American
medical education and that
the total educational experi
ence here is a rewarding one,"
says Dodson. LJ

showed symptoms of writer's
cramp. 'This was a surprise,"
Tempel says. "It tells us that
writer's cramp involves more
of the brain than we might
otherwise have thought based
on clinical observations. This
may be reflected by the obser
vation that about a quarter of
the people with writer's cramp
in one hand will train them
selves to use the other hand
and will subsequently develop
writer's cramp in that hand."
Despite these new find
ings that implicate the senso
rimotor and supplementary
motor areas of the brain in
writer's cramp, much remains
to be learned about how the
brain contributes to this con
dition. Though this study
sheds new Iight on the disor
der, it will not bring an
immediate improvement in
therapy, Tempel says. "But
the better we understand
what's happening in the brain
to produce writer's cramp,
the better our chances of even
tually improving treatment." •
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0m no good ... I can't do anything right '" I'm a burden to
my family ... They'd be better off if I were dead ..." Such

thoughts breed unchecked jn the minds of many depressed people.
Proponents of pop psychology sometimes call these run1inations
"negative tapes" -

mental recordings from childhood of the

voices of critical, unloving family members. All too often, they
drive their listeners to self-hatred, sometimes even suicide.

The PET scanner works to
reveal comparisons between
normal brain junction and
brailljullctioll when things
have gone awry.
8
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ome negati ve ta pe s, howe ver, have
nothin g to do with dy sfun ct io nal
families or o ther traumati c c ircum
sta nce s. For these de pressed peo ple, mi s
ery is a matte r of the brain' s c hemi stry
gone awry. Recovery de pend s largely o n
antid e pressant dru gs. But no o ne has
und e rstood the brain 's prec ise fun c ti o n in
thi s type of illness, nor ho w antide pres
sants exactl y wo rk. M a ny clues have led
psyc hi atri sts to hypo thesi ze a neuro logi
cal pathway for de press io n th a t includes
brain structures responsible for me mo ry
and emotio n.
Thi s specul atio n is no w gi ving way to
proof. With th e imag ing po we r o f posi
tron e mi ss io n tom ogra phy, o r PET, a
research tea m led by Wayne Drevets, M.D .,
has appare ntly mapped the ro ute of the
nega tive tapes. A type o f ph ys iologicall y
based de press io n cause s pa rts o f the brain
to " li ght up" in PET im ages.
"The re 's ev idence o f an e ntire a nato m 
ical c ircuit that see ms to fun ction abnor
mally du rin g de pressio n," says Dreve ts,
an ass istant profe sso r of psyc hiatry. " A
cons iderabl e am o unt or e vidence sug
ges ts th at thi s c irc uit mLi st be involved.
Ours are the fi rs t im ag ing da ta that co r
ro bo rate this. "
Unde rstandin g thi s de press io n c irc uit,
says Drevets, ma y lead to bette r antide 
pressa nts . The goal is to s i le nce th e terri
bl e nega ti ve tapes.

S

I'
I

I
I

I
I

I
I

I

Trait And State
, I

T
A PET scan reveals the difference in depressives ' brain activity while experiencing
depression and when in a remitted state. The images show an entire anatomical cir
cuit that appears to function abnormally during depression. Th e notation "VLPFC"
refers to the ventrolateral prefrontal cortex.

10

o study the anatom y o f de pres 
sio n, Dre ve ts foc used o n a varie ty
o f th e d isease that wo uld yie ld the
mos t mea ningful PET data . First, Drev ets
examined not th e sort o f tran s ie nt sadn ess
assoc iated with g rief o r hard ship, but
maj o r depress ion . Thi s iLlness, affec tin g
15 perce nt of the populatio n at o ne time
o r ano the r, can di sturb a pe rson's ea tin g
and sleeping patterns, destroy hi s a bility
to e nj oy pl e asure a nd haunt him with
pe rsistent tho ughts of fa il ure, loss , gu iIt
and dea th.
Dre vets had to c hoose be tween the
two ca tegor ies of maj o r depress ion: bipo 
lar and unipolar. Bip o lar de pressives
ex perience episodes of m a nia as we ll as
bo uts o f depress ion. Unipolar depres

sives , who constitute roughly 90 percent
of all depressed persons, do not have
manic episodes.
Whil e unipolar de press ion rese mbles
the "blue" phase of its bipolar counter
part, says Drevets, the two illnesses are
physiologically distinct. Structurally , the
brains of unipolar depressives are no dif
ferent from th ose of the non-depressed.
Not so for the brain s of bipolar depres
sives; their cerebral ventricles - the flu
id-filled spaces in the center of the brain
- are larger, for example. Because the se
physical differences would confuse PET
comparisons between bipolar depressives
and normal subject s, Drevets opted to
study unipolar depress ion.
To further simplify hi s research , he
selected unipolar subjects from a catego
ry called familial pure depress ive disease
(FPDD). These depressives had a de
pressed parent, sibling or offspring but
no family history of alcoholism , antiso
cial personality or mania.
"This is the first PET ex periment that' s
tried to subgroup patients to this extent,"
says Drevets. "I think that 's why we were
so successful. We obtained a relatively
homoge neous group of people likely to
have similar abnormalities."
In PET, radioactive trace rs that emit
positrons are injected into a person' s
blood stream. The tracers gravitate to
biologically active tissues by virtue of the
compounds to which they are linked.
Drevets' tracer was water with a radio
active oxygen atom. It tracks blood flow,
a good mirror of neural synaptic activity.
The positron s collide with electrons in
the ti ss ues, producing gamma rays. These
rays are recorded by the doughnut- shaped
PET scanner that encircles the subject. A
computer converts the data into a three
dimen sional image.
The psy chiatrist assembl ed three sub
ject groups - I 3 people with FPDD who
were curTently depress ed, 10 people with
FPDD who were in remission (that is,
displaying no symptom s), and 33 control
subjects with no personal or family hi sto
ry of psychiatri c illness. Tom O. Videen ,
Ph.D., a research assistant professo r of
neurology , used a computer program to
transfo rm individual PET scans into a
composite image for eac h group, despite
differences in brain shape and head posi
tion insid e the scanner.
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This map shows precisely where the increased activity is centered. Oil the right (B
alld D), are line representations of the braill shape alld (E) the level at which the two
PET slices were recorded. Oil the left, two color images localize the increased braill
activity of depressed patiellts.
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Wayne C. Drevets, M.D.
"We bend and stretch and shape the
images so they all line up,"' say s fellow
researcher Marcu s E. Raichle, M.D., pro
fessor of radiology and of neurology.
Videen also refined the data to minimize
altificial differences between the com
posite images due to "statistical noise."
Comparing the brain images revealed
simple but profound distinctions. In con
tra st to the control group, the subjects
with active FPDD showed increased
blood flow in two regions. One area of
increase was the prefrontal cortex of the
brain ' s left cerebral hemisphere. (The
cerebrum, which gives us the word "cere
bral," is the large, prominent brain ma ss
that' s fissured like a walnut. The cortex
is the thin lay e r of wrinkled gray matter
covering the cerebrum , literally the brain ' s
thinking cap.) The frontal cOltex governs
decision-making. problem-solving and
mo tivation. The prefrontal cortical area
defined in the PET study may use a kind
of short-term memory to guide behavior
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wake up at 2 a.m.

and smell smoke. TIlt'
aJny~dala lc-lIs the fest of
your hrain, '''Be afraid!'·
when external cues - such as verbal
directions - are lacking. Drevets achieved
a methodological first by identifying the
precise area of the prefrontal cortex in
which blood flow is elevated in patients
with depres sion.
Previous PET studies of depression
looked for irregularities in specific bra in
regions. Drevets, figuratively speaking,
went in blind. He divided the 13 depressed
subjects into two groups, each with a se p
arate control group. For the first set of

depressed and normal s ubject s, he pro
duced composite PET images of the entire
brain. After spotting the overactivity in
the pre frontal cortex among the depres
sives, he focused his attention on just this
particular region in the second set of sub
jects - and found the same quirk.
PET also detected increased blood
flow among the depressed subjects in the
left amygdala. The s ize and shape of an
almond, the amygdala belongs to the lim
bic system , a group of stmctures unde r
neath the cerebral hemispheres. The
limbic system processes sensory input,
adjusts bodily settings for temperature
and blood pressure and generates emo
tional respon ses . Some neuroscienti sts
theorize that the tiny amygdala's job is
assigning emotional significance to exte r
nal stimuli. You wake up at 2 a.m. and
smell smoke. The amygdala tells the rest
of your brain, "Be afraid I" But when you
wake up at 7 a.m. and smell frying bacon,
the amygdala might trigger a neurochem

ical chain reaction that ends with a smile.
Neuroscientists are honing in on this
brainy "spin doctor" as a possible culprit
in a variety of emotional disorders. Stim
ulating it with electricity can evoke fear
and hallucinations. Monkeys whose
amygdalas have been destroyed succumb
to "psychic bl indness." They lose their
fear of normally alarming stimuli, such
as the sight of a snake.
Like subjects who were currently
depressed , FPOD subjects in remission
also had elevated blood flow in the
amygdala. But remitted subjects demon
strated no such increase in their left pre
frontal cortex. Orevets' tentative
conclusion? Heightened blood flow in
the amygdala represents a "trait" marker
of FPDD "that may predispose them to
depressive episodes." Heightened blood
flow in the prefrontal cortex represents a
"state" marker - when the patient is dis
playing symptoms.

A Lack of Inhibition

T

he provocative hypothesis of trait
and state markers awaits more veri
fication, but anatomical anomalies
in depression raise more possibilities
when examined in the context of neural
circuits. The amygdala and prefrontal cor
tex form a circuit together with the
mediodorsal region of the thalamus. In
general, the thalamus is a processing sta
tion for all sensory information except
smell. The mediodorsal thalamus fires off
neurotransmitters to the prefrontal cortex,
which in tum, rings up the amygdala. The
amygdala completes the circuit by talking
to the mediodorsal thalamus .
The same circuit also operates in re
verse, except that no messages travel from
the mediodorsal thalamus to the amyg
dala. Breaking the circuit dramatically
alters behavior. Sever the amygdala from
the prefrontal cortex , and you have per
formed an emotion-deadening lobotomy.
This three-part loop belongs to an
even larger circuit that includes the ven
tromedial section of the caudate and the
ventral section of the pallidum, both parts
of the limbic system. Normally, the ven
tromedial caudate retards the firing rate
of the ventral pallidum, which does the
same to the mediodorsal thalamus. The
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larger circuit, therefore, tends to modu
late the smaller circuit.
The PET study , says Drevets, appears
to confirm what neuroscientists have long
suspected: Disruptions in these two cir
cuits playa key role in physiologically
based depression. In FPDD, the amygdala,
prefrontal cortex and mediodorsal thala
mus may act "like a circuit running away
with itsel f," with the amygdala putting
negative labels on all incoming sensory
infonnation, or failing to assign any posi
tive labels. This hyperactive loop, he says,
may thus explain the "negative tapes" that
play in some depressed minds.
So what about the larger neural circuit
that's supposed to calm down the smaller
circuit? PET scans suggest an apparent
glitch in one of the larger circuit' s stops
- the ventromedial caudate. The struc
ture is one area of decreased blood flow
in the brains of depressed subjects. Drevets
says the blood-flow abnormality might
be due to the ventromedial caudate not
receiving enough of an inhibitory neuro
transmitter called dopamine. An unre
strained ventromedial caudate, Drevets
reasons, overinhibits the ventral palJidum.
According to the curious laws of neuro
chemistry, that leaves the ventral pal
lidum unable to curb the mediodorsal
thalamus. So the smaller circuit buzzes
even more.
Other mental disorders share the qual
ity of irrational mental fixation found in
depression. Not surprisingly, Drevets and
his colJeagues are aiming PET at subjects
suffering from panic disorders, simple
phobias and obsessive-compulsive behav
ior. PET studies in depression will con
tinue as well. One possible experiment
involves treating depressed subjects with
antidepressants and looking for s ites of
increased or decreased brain activity.

Such a study, Drevets says, may explain
more precisely what the drugs do. These
pharmaceuticals typically lift spirits by
correcting imbalances of neurotransmit
ters like dopamine, serotonin and nore
pinephrine. Many people with unipolar
depression simply don't have enough of
them. Interestingly enough, Drevets notes,
most antidepressants "act as amygdala
depressants." He speculates that dopamine
shortages in the amygdala as well as the
ventromedial caudate could account for
the runaway brain circuitry in depression.
Orevets doesn't discount the impor
tance of "talk therapy" as he seeks the
physiological source of the ilJness. "If
you break your leg, you need a cast so
the bone will grow back together, but
then you have to exercise your leg because
your muscles have become weak. Anti
depressant drugs are the cast. Psycho
therapy is the rehabilitation."
The desire to formulate more effective
antidepressants is a profound one for
Orevets. "Our hope is that we'll be able
to tell what treatment will be best for a
depressed patient based on PET scans.
The way it is now, it's trial and error. You
try one antidepressant and see if it works.
That may take six weeks. You then raise
the dosage or add something to it. If that
fails, you switch to a new one ."
While a psychiatrist searches for the
right drug, the depressed patient contin
ues to suffer the onslaught of the nega
tive tapes: "] can't do anything right.
Nobody loves me . My life is worthless."
Drevets wishes he could have ended this
morbid interior monologue for one of his
depressed patients who participated in
the PET study. She was a 50-year-old
woman with a lot going for her - a loving
family, a supportive church, a successful
career. Neither drugs nor psychotherapy
could dispel her gloom. Last summer, she
took her life. "It's people like her who
motivate me to work hard on the research, "
Drevets says.
Although PET images from his exper
iments look abstract and high-tech, Drevets
remembers the faces of people who
struggle with tormented thoughts. The
science may be complicated, but the goal
is basic medicine - alleviating another
person's suffering. And replacing nega
tive tapes with positive ones. •
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Researchers Develop A BiocompatiJlle Breast Implant
B Y
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C ontroversies have waxed and waned over
the use of silicone gel breast implants during
the 30 years since they were first introduced.
From moral questions to accusations that the
implants cause cancer, the subject has been
bandied about repeatedly. Recently, feverish
debate about possible effects on systemic
health has been played out in the press. The
February decision by an advisory committee
of the FDA recommending limited use and
further study of silicone implants did little to
end the disagreement.

Oil- and silicone-filled implants can be made with similar tactile characteris
tics. Both ofthese - the smaller oil-filled prototype and the traditional sili
cone-filled implant - are encased in texturized silicone envelopes.
14
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On the left is a mammogram of a breast augmented with a silicone gel implant. On the right: the same breast augmented with an
implnntfilled with organic oil. The mammographer's view through the oil-filled implnnt clearly shows the simulnted microcalcifi
cations blocked by the radiopaque silicone.
"It's unfortunate that the argument has
become so emotionally charged," says
plastic surgeon V . Leroy Young, M.D.,
professor of surgery. "The debate has left
science behind and is running on rumor. "
Having performed more than 1,000
implant operations and cared for women
with apprehensions about their implants,
Young is familiar with the concerns.
Unsubstantiated fears he works to calm.
But real problems have prompted him and
his colleagues in their research to develop
an alternative to silicone implant s.
"Women should be able to do what
they want to with their bodies," says Judy
M. Destouet, M.D ., associate professor of
radiology and one of the research team's
members. 'They should have access to
breast reconstruction without worry. If
they want larger breasts, they should be
able to have them. We want to provide an
implant that has been thoroughly tested
and is presented with its risk s known."

16

Biocompatibiity
The researchers' new implant addresses
concerns about silicone. Because the filler
is a purely organic oil, such as peanut oil
or safflower oil, Young says the body 's
normal metabolism clears any that escapes
or bleeds from its envelope, an occurrence
that cannot be avoided completely.
Studies in which peanut oil was injected
into and surgically implanted in laboratory
animals showed no adverse effects. "We
saw no difference in response to the peanut
oil and to simple saline. The peanut oil is
simply absorbed, much the way that the fat
we eat every day is absorbed," Young says
of the test results.
Further laboratory studies in which
peanut oil molecules were tracked after
labeling with radioactive tracers showed
th at the oil was redistributed to the ani
mal 's body fat and assimilated. None of
the animals in the study exhibited rashes,
elevations in temperature or gave any

other evidence that an immune response
had been triggered, Young reports.
"When we began to investigate the
possibility of using peanut oil as an im
plant filler, we discovered an enormous
body of existing research to support its
safety," Young says. Its use as a carrying
agent for injectable time-release medicine
is well-documented , and the oil is classi
fied by the Food and Drug Administration
(FDA) as "generally accepted as safe,"
the researchers report.
Even the ques tion of whether those
who are allergic to peanuts would be
allergic to the implants has been addressed.
Young says the protein fraction that initi
ates a reaction to peanuts is chemically
removed from the oil, eliminating the
potential for an allergic response on that
score. To test whether the organic materi
al might spoil, Young and his colleagues
inoculated samples with bacteria and incu
bated them. But the colony counts dropped

off; the purifi ed oil does not support bac
te rial growth. And all odor is removed
from the oi I.
Such documented biocompatibility
goes to the heart of the recent furor over
silicone. For several yea rs , anecdotal
evidence has been bui ldin g concerning a
variety of responses to silicone. Women
and their phy sician s have reported sclero
derma (a hardenin g and stiffening of the
skin) , arthritis-like joint problems, lupus
erythematosus (a complex connective ti s
sue disorde r), shootin g pains, rashes and
other ailment s that they beli eve to be
attributable to silicone escapin g from its
envelope and mi grating.
BUI Young says it has not been been
possible to show a causa l relationship
between these disorders and silicone:
"There has never been substantiation for
the c harge th at silicone impl an ts cause
ca ncer, and there 's no real scientific proof
that they are respon sible for these other
problems, either. " He adds that neither is
there proof that si Iicon e is not respon si
ble. Scienti sts have been unable to create
a monoclonal antibody to silicone that
would allow the m to accurately demon
strate it s allergeni ci ty.
Still, case report s are becomin g more
common and convin cing, witness the
FDA's recent moratorium on implants
to allow furth er study. And the identifica
tion of a human antibody to silicone by
researc hers at the University of Texas
Medical Branch suggests that some
people 's immune systems respond to
its presence.
The issue is complex. Young says sc i
ence was "plodding along," trying to fig
ure it out, when the heat was turned up.
Ts silicone absolute ly inert or does it
change over time ? Mi ght silicone form a
complex with a protein or proteins that
triggers a response? No one knows. With
a well-tested pea nut-oil filled implant ,
the risks that ex ist will be quantified .

Mammography
The concept for a peanut-oil filled
implant was born from a sea rch for an
alternative that was radiolucen t - one
that allowed X-rays to pass unobstructed.
At the exposures used for manunogra
ph y - the technique universally regarded
as the best tool for detecting occult breast

Plastic surgeon V. Leroy Young, M.D., seeks an alternative to silicone gel breast
implants - one with proven biocompalibility.
cancer - si licone is radiopaque; that is. it
blocks the passage of X-ray s. A physician
loo king at a film of breast ti ssue exposed
through a silicon e-filled envel ope sees
nothin g but a white mass - no detail, no
tissue, no calcifications, nothing.
The opac ity is a function of silicone's
atomic number, a measure of its relative
atomic den sity. With an effective atomic
number of 16, si licone is a poor match
for average breast ti ss ue's atomi c number
of 6.0. When John Eichling, Ph . D., asso

ciate professor of radiology and a mem
ber of th e development team, rested
peanut oil. he discovered that its atomi c
number was 5.9. X-rays pass through it
sl ightly more eas ily than they do through
breast tissue, making it radiolucent.
A study by Destou et and Barbara
Monsees. M.D., assoc iate professor of
radiology , compared a number of fill
materials in a silicone envel ope and deter
mined that impl ants filled with peanut oil
or safflower oil allowed the greatest visu
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alizi.ltion of microcalcifications and soft
tissue masses, early indicators of breast
cancer. Even saline sol ution, with an
atomic number of more than 7, is not sat
isfactorily ri.ldiolucent, Destoue t says. An
estimated 2 million women in the United
States have breasts augmented with sili
cone. Only now, Destouet says, are li.lrge
numbers reaching their 40s and 50s, ages
at which sc reening mammography be
comes essential. At the current rate, one in
nine American women is expected to
develop breast cancer in her lifetime.
At least one study has shown that
wome n with silicone implants are diag
nosed with breast ca ncer at later stages,
with more invasive lesio ns and with
greater involvement of the lymph nodes
than those without implants. One reason:
Silicone implants block the radiologist' s
view. That's es pecially true of the upper
outer quadrant of the breast where more
than 50 percent of breast cancers begin,
says Destouet, an expert in mammogra
phy at the medical sc hool's Mallinekrodt
Institute of Radiology and director of th e
Breast Diagnostic Center.

Even in the best -case scenario, 10 per
cent of breast ti ss ue is obscured by a sili
cone implant. That figure is for wome n
with so ft, compressible breasts and small
implants who visit trained mammogra
phers for the spec ial views recommended.
Some studies have shown that as much as
80 percent of the breast ti ss ue can be radio
graphically obscured by a silicone implant.
Destouet points out that implants a lso
require more views of the breast to be
made, with a subsequent increase in radia
tion. "A t least four exposures, instead of
two, are necessary," she says. The addi
tional " modified compressed views" are an
attempt to move breast tissue away from
the implanl in order to detect abnormalities
that could indicate the presence of cancer.
Beyond that , the radiodensity of implants
often defeals a mammography machine 's
automatic exposure control , making addi
tional test exposures necessary.

COl1lracwre
A third issue that the new implant
must address is that of capsu lar contrac

ture - essentially scar tissue that the
body often builds around an implant,
turning it hard, noncompressible, more
spherica l and frequenlly painful. The
problem occurs in perhaps 40 percent of
all women who receive smooth silicone
implants, Young says, although so me
studies put the numbe r even higher.
Young ex plain s that capsular contrac
ture occurs when the body responds to a
forei g n object - in this case the implant
- by depositing collagen. Common wi s
dom says that the envelope's smooth sur
face allows the collagen to build up in a
highly symmetrical pattern. Fibroblasts
in the collagen then contract and com
press the implant uniformly, making it
more spherical and forming a hard "s hell. "
A silicone-fill ed implant briefly avail
able with a textured polyurethane foam
coating reduced the incidence of contrac
ture to about tw o to fiv e percent, Young
says. It is thoug ht that the textured surface
disorgani zed the collagen so that it was
deposited in a bizarre array, with its forces
vectored. "Plu s," Young says , " the body
likes textured surfaces . They ' re more self

Speaking Persona]]y
uch of the controversy over sili
cone gel breast implants can be
traced to the very different experi
ences women have had with them.
Barbara B., a 52-year-old small
town resident underwent a mastectomy
nine years ago and chose to have a
reconstruction using silicone implants.
Within two years, she suffered chron
ic fatigue, experienced severe joint
pains that made it difficult for her to
get into her car and became allergic to
house dust and mold lhat had never
bothered her before. Worst, she reports
developing an auto-immune disorder
that was eventually diagnosed as chron
ic active hepi.ltitis.
"I never put two and two together
until last winter when my sister called
to tell me i.lbout a report Connie
Chung was doing on television. She
described me exactly," Barbam says.
After consultation, V. Leroy Young,
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M.D ., performed surgery last spring
to remove Barbara's silicone implants
and replace them with a saline-filled
version . He found the original implants
ruptured, their gel filler extruded with
many silicone granulomas, or small
nodular aggregations.
"Within three weeks, my joint pain
Wi.lS gone and I had my energy back.
Now , I'm much better," Barbara re
ports. She says she holds no hard feel
ings, certain that her first surgeon told
her all that he knew at the time but
slIre that the silicone was the cause of
her health problems . "I don't regret it,
even though I suffered," she says.
Kim H. is 27 and has had her sili
cone-filled implants for seven years,
since the birth of her first child left
her unsatisfied with the appearance of
her breasts. "I felt terrible about myself.
I couldn ' t wear a swimsuit. and I didn't
look good in my clothes," she Si.lyS.

Delighted with the results of her
augmentation, she says, " I've had no
bad reactions whatsoever, not even
any contracture. Immediately after the
operation I felt better about myself. I
still would recommend that a woman
considering the operation go ahead."
A healthcare worker, Kim sees
women with implants who are wor
ried, and she comforts them. ''\'m not
scared. So much of this is paranoia.
I'm not saying some women don't
have problems, but some of what you
hear is ridiculous," she says.
Kim hi.ld her first mammogram
last year and says she was not told
until recently that s ilicone implants
might interfere with effective mam
mogri.lphy. "If peanut oil implants be
come available, I'll probably change
to them just to get better mammo
grams," she says.
-S .K.

like than smooth surfaces. " But the foa m
covered implant was discontinued when it
was determined that its polyureth ane coat
in g degraded into chemicals known to be
carcinogens in animal s.
The issue is confu sed by a Swedi sh
stud y comparin g impl a nts filled with
saline and sili cone gel , all with smooth
silicone envelopes. Th at research showed
that 50 percent of the sili cone-fill ed
implants suffered contrac ture, but onl y
16 percent of the saline-fiJl ed impl ant s
were affected. The sugges ti on: It was not
the texture of the impl ant 's envelope th at
initiated capsular contracture but rather
silicone bleeding from the impl ants.
In any event, Destouet says the oil
filled implant will not have a sili cone
envelope: "Silicone is out. The ca psul ar
contracture of smooth sili co ne envelopes
mea ns th at the breast ca nn ot be com
pres sed effec tive ly fo r mammog raphy.
And tex tured sili cone th at mi ght solve
th e capsul ar co ntrac ture proble m appears
like a fine mes h on a mammogram. That
mes h could eas il y o bsc ure sma ll tumors."

~

Development
Fro m Desto ue t and Youn g's ea rl y
inte res t in the potential for an alte rnati ve
breas t impl ant has evolved a compl ex
effort to serve women. Now under devel
opment by a pl asti c surgery firm , peanut
oil- fill ed implants still face a long trial
and a pprova l process .
Accordin g to Brian Cle vinger, Ph.D. ,
wh o manages the further development of
the projec t and whose efforts secured a
patent on radi olucent implants for the
university, the issues are:
I) The impl ant mu st be filled with a
bi oco mpatibl e, radiolucent substance that
prese nts no threat, even upon release into
the syste m. It mu st also provide a natural
fee l and sha pe. Triglycerides like peanut
oil a lready meet mo st of these criteria,
and tec hniques under development by
orga ni c che mi sts promise to provide the
necessary co nsistency.
2) Th e impl ant e nvelope must not in
vite ca psular contrac ture, must in no way
inte rfe re with mammograph y and must
mainta in its integrit y. Clevin ger say s
these require ments probably dictate an
entirely new materi al for the e nvelo pe
a ft er exte nsive testing of candid ates . Ne w

.Judy M. Destouet, M.D., director of MaLLinckrodt Institute of RadioLogy 's Breast
Diagnostic Center, says "Silicone is out," even if it is onLy as the materiaL that forms
an implant's enveLope.
material s th at main ta in long-term integri 
ty and do not degrade into hazardous
substances hold great pro mi se, he say s.
Texturi zati on of the surface is likely.
3) All of these iss ues mu st be dealt
with in the contex t of the th e pre- market
approval required by the FDA. Because
breast impl ants now are li sted as Cla ss
Ifl dev ices by the FDA , Cl evin ger expects
full federal sc rutin y to be brought to
bea r. "We don' l know what the FDA

will require. We may meet all pu bli shed
requiremenls only to be told th at we have
to provide 10 years of clinical tri al results,"
he says. "It is a bold step into a very bi g
abyss to try to do something about thi s."
The only guarantee th e research tea m
can offer is that when the alternative
implant becomes availabl e, it will have
been thoroughly tested. The ri sks assoc i
ated with it will be known . •
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orne people tie string around a
finger to remember their purpose. David Gottlieb, Ph.D ., keeps a

.~

I

black and white photograph on the bulletin board in his office to
remind him why he' s a neuroscience researcher.
Two dark bands of raw data from an old experiment are all
that's visible in the image. The picture forces Gottlieb, a professor
of anatomy and neurobiology, to concentrate on what he call s the
"development question :" How do genes operate to decide the fate
of growing brain cells? Gottlieb relies on the photograph because
recently he and hi s colleagues at the medical school have been
thru st unexpectedly into the world of diabe tes research , a strange
place to find neuroscienti sts interested in the fate of nerve cells.

By Jim Keeley

1

l
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a dramatic improvement
over the then-current
understanding.
Gottl ieb chose to study
neurons that make GABA,
a chemical that applies the
brakes to nerve impulses.
He reasoned that because
about one out of every four
nerve cells in the brain pro
duces this chemical, it mu st
be important to neural func
tioning. Gottlieb explains
that just as some brain
chemicals initiate impulses,
others mu st limit them .
Moreover, effective and
widely prescribed drugs
such as Valium are aimed at
the GABA receptor, where
they slightly increase the
activity of the so-called
inhibitory neurons . The
result is that feel ings of
tranquility are enhanced.
Actually, GABA wasn't
Neurons in the cerebellum stained with the monoclonal antibody to GAD obtained by David
the real prey. Gottl ieb
Gottlieb, Ph.D., and his colleagues. Only neurons containing GAD are stained. Sera from patients
began by stalking GAD, or
with stijj~man syndrome show a similar staining pattern., Gottlieb says. The photomicrograph is
glutamic acid decarboxy
by Thomas A. Woolsey, M.D.
lase, at that time a poorly
characterized enzyme that
The resea rch team was pursuing a bet
All of this is terra incognita for a neu
sc ientists knew descriptively as a
ter way to track down a particular brain
roscientist. Diabetes research and neuro
molecule that cleaved a carbon off glu
protein, Gottlieb recalls. But in one of the
science see m unlikely to come together
tamic acid, thereby producing the func
in a single laboratory investigation. But
detours that so metimes affect basic re
tional neurotransmitter GABA. "We
search. the group unknowingly fashioned
in Gottlieb' s view of science, the coinci
thought GAD would prove to be very
a tool th<Jt captured a major culprit in
dence is unremarkable. He says he always
important because you can't find a cubic
juve nile diabetes.
ha s operated under the premi se that basic
millimete r of gray matter that doesn't
More appropriately called insulin
science can and will make direct contri
have neurons thal produce it," Gottlieb
dependent diabetes, that disease has a
butions to the trea tment and understand
says. "And without GAD , a neuron will
peak age of onset of 12 years but can
ing of human diseases. This work affirms
never make GABA. "
strike those into their 40s as well. It ren
his beli ef and goes it one better. "It also
Before Gottlieb could dctennine the
ders patients dependent on external
shows that by following a line of ques
answers to his first major questions 
sources of insulin to sustain their lives.
tioning that makes a lot of sense in your
where and when GAD appeared in nerve
The National Institute of Disease Control
own basic field, you can sometimes make
cells - there was an iss ue to clear up:
estimates th<Jt 14 million American s live
a contribution to a cl inical area that you
He had to find out exactly what GAD
with diabetes, though how many are
didn ' t really intend to," Gottlieb says.
was. "At that time , we had to step back
in sulin-dependent is difficult to assess
from our developmental questions because
because the di sease often progresses into
people didn't really know what GAD
The Origins
insulin dependency .
was. GAD had been partially purified ,
Investigating diabetes, labs around
Six years ago, Gottlieb chose to look
but it was still imposs ible to say which
the world use Gottlieb's monoclonal anti
for genes that influence the destiny of
proteins were really GAD," Gottlieb says.
body, GAD 6, as a way to detect an anti
immature nerve cells. A topic of increas
In a twi st ot" fate, Gottlieb and post
gen that is central to its cause. And there's
ing interest at the time, the field was
doctoral fellow s Yen Chung Chang and
hope that an early screening test for juve
wide open. Jt was an exciting period,
Jim Schwob decided to attack the prob
nile diabetes based on this technology
Gottlieb recalls , because even a modest
lem by obtaining a GAD-specific mono
will soon be developed , Gottlieb adds.
increase in knowledge would represent
clonal antibody, a protein designed to
22

reach into the crowd of proteins normally
found in brain tissue and grab only GAD.
Using their monoclonal antibody, named
GAD 6, as a probe, th ey were surprised
when th ey discovered two GAD protein s.
The two protein s - named GAD I and
GAD 2 - differed in wei ght but were
about 70 percent similar in composition.
Finding two GAD proteins was a su rprise,
and several groups are still trying to fig
ure out the functional difference between
the two .
At abo ut that time, scientists led by
Pi etro Camilli, M.D., at Yale University
were stud yin g patients with stiff-man
sy ndrome - a rare, paralyzing neuro log
ic disorder. They contacted Gottli eb when
their work showed that stiff-man sy ndrome
somehow caused patients to manufacture
antibodies that attacked their own supply
of GAD . This immune system revolt, it
wa s later learned, contributed greatly to
the progres sion of the disease. "Thi s was
a completely fortuitous finding," Gottlieb
notes. "Researchers also found th at the
disease results in death from an attack on
inhibitory neuron s in the brain."
Investigators then learned that a num
ber of patients with stiff-man syndrome
were also stri cken with insulin-dependent
diabetes. As fate would have it, a group
of scientists led by Steinunn Baekkeskov ,

Ph .D., at the University of California San
Francisco (UCSF) Medi ca l Center hap
pe ned to be trackin g an antibody in the
blood of juvenile diabetes pati en ts. The
antibody attacks a protein with the
approximate molecular weight of GAD .
'The GAD 6 monoclonal antibody th at
we developed proved to be crucial in
es tablishing the identity of the antigen ,"
Gottlieb says.
Just as brain cells do, in sulin-produc
ing cells in the pancreas synthesize GABA,
although medical sc ienti sts don't yet
know why. Because GABA is present in
the pancreas, so is GAD . One theory
holds that when an immune system goes
awry by producin g an antibody that
attacks GAD, the body 's insu lin produc
tion is interrupt ed. The res ult is insulin
depe ndent diabetes. Anoth er theory is
that GAD is an innocent bystander to the
injury to the in sulin-prod ucing islet cells,
and the culprit lies elsewhere. "Either
way, GAD is diagnostically important,"
Gottlieb says.
Today , laborato ries around the world
use the GAD 6 monoclonal antibody for
diabetes re searc h and to develop clini ca l
tests. The antibody is di stributed freely;
if a scientist needs it for research, all he
or she mu st do is pick up the phone and
call the NIH-sponsored hybridoma bank

that stores it or call Gottlieb directly.
Researchers in at least 60 labs are using
the antibody, Gottlieb says, and the num
ber may be con siderabl y higher.
The presence of the antibody to GAD
in the blood is one of th e earliest known
signs of in sulin-depend en t diabetes . Now
that physicians have the tools for detect
ing anti-GAD antibodi es in the blood
stream, they can screen pati e nts at risk to
see if their bodies are attacking GAD.
The potential clinical impac t of a screen
ing test for diabetes is enormou s, beca use
patients often have lost 90 percent of
their islet cells before they reach their
doctor' s office. To diagnose pat ients ear
lier mi ght mean sav ing man y of those
cells and their function.

II
i

taying At The Bench
Havin g answered the question of what
GAD is at the molecular level , Gottlieb
and hi s colleagues - [lost-d octoral fel
lows Gerard Bain and Mich ae l Morales.
technologist Min Yao and student Ben
Abella - are returning to basic ques tions
in developme ntal neurobiology. In partic
ular, they want to uncover the mecha
nism s by which inhibitory neurons dec id e
to express the GAD gen es.
Plans hav e been mad e to devel op
tran sgenic mice as a mea ns of taking a
closer look at how nerve cell deve lop
ment is innuenced by GAD. The mice
will have their gene for GAD deleted,
and the consequences of that deletion
will be assessed. There' s also excitement
about in vitro cell lines that will pemlit
the study of GAD ex press ion outside the
living brain. "At th e moment, we have a
good timetable show ing when these cells
express the GAD genes, but we're com
pletely in the dark about th e signals that
determine neura l cell fate," Gottlieb says.
Before movi ng on to address that
issue, he comments abo ut the detour in
his deve lopmental neurobiology research:
"We always hoped the ba sic work would
result in a clinical tie-in, and we were
very gratified when it did . This is one of
many instan ces in whi ch the assumption
that support for basic research will even
tually produce clinic ally important results
was validated." !!I

After making a major contribution to clinicaL investigations into diabetes, the GottLieb
lab has returned to the pursuit of basic science.
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Student Stage
A eeliell Addit,ioll
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By Marion H un!
hen Aph rodite
JannopouJo entered
Was hington Uni
versi ty School of Medic ine in
19 18 as one of the fir st two
wo men admitted to the full
four-year course of study , she
co nfided to her di ary: "At
las t my dreams are rea lized ...
Caro l Skinne r Co le and I are
the on ly women in the class,
so we wil.J have to bra ve the
storm alone." Her pride in
rea lizing one of her life's

Ll mbi tions was tempered by
the knowledge that being
among the first women stu 
dents wo uld present special
challen ges.
Now that women are ro u
ti nely ac cepted as medi cal
st udents and phys icians, what
Aphrodite Jann opoul o meam
by "the storm" may be hard
to unclerstand . Howe ver, until
rece nt yea rs, women who
wa nted to enter science or
medi cine faced seri ous oppo 

lIntil 1'(-,(,(-"111 Vt an;.,

who ,"ranted to rntLr sr,ien( ~ e or
lllt.. .}j( illt-' fact d st-'riou!'\

opposition.

I ,

Patricia L. Cole, M.D., associate dean of student affairs, and medicaL student Nancy MacDonaLd.
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siti on. Their ability and com
mitme nt often were doubted,
and th e doubts were used as
an exc use to restri ct admi s
sion and training opportuni
ties for women.
Since the 1960s, women
have become an increas ing ly
signifi cant presence in sc ience
and medi cine. However, eve n
now they mu st meet parti cu
lar challe nges durin g their
caree rs that their mal e class
mates and co ll eag ues seldom
encounter. Men combine
caree r and fa mil y as a matter
of co urse; fo r women, havin g
successfu I caree rs and fulfill 
ing family lives requires superb
pl annin g and tac ti cal skills.
A ne w Program for Wom
en in Science and Medicine
ha s bee n in operati on here for
just over a year to assist wom
en. Dea n Willi am A. Peck,
M.D., says the program was
establ ished beca use "Was h
ington Uni ve rsity Sc hool of
Medi cine is abso lutely com
mitted to pro motin g the aca
demi c grow th and caree rs of
wom en. " Headed by Patricia
L. Col e, M.D., associ ate dean
of student affairs, the program
provid es a ne twork of faculty
advisors fo r differe nt ca reer
choices and a fo ru m fo r for
mal and inform al disc uss ions
about topics of pal1icul ar con
cern to wo me n ph ys ic ians
and sc ie nti sts. In add iti on,
Cole's offi ce serves as a liai
son between th e American
Medical Women ' s Assoc ia
tIon, the Women's Section of
the AMA an d the med ica l
school 's Acade mi c Women's
Netwo rk , a women's fac ult y
orga ni zati on. Another of the

program's goa ls is to en hance
the quality and qu antity of
women applicant s.
Trained as an inv as ive
cardiologist, Cole dec ided to
head the program because o f
her strong belief th at it coul d
ma ke a significant improve
ment in women 's pro fess ion
al li ves durin g their stude nt
years and beyond . Th ough
ne w, the program is already
having positive effec ts. First
yea r medical student Nan cy
MacDonald says that "it was
a defi nite fac tor" in her dec i
sion to co me here . Of 10
medi ca l sc hool s she cont acted
dUli ng the admi ssions process,
onl y Was hington University
gave her in fo rm ation about a
specia l prog ram for women.
"Th at showed an interest and
se nsitivity th at immediately
allrac ted me," she says.
Mac Donal d 's parents are
ped iatri cians who practice
out of lheir home , so Nancy
lite rall y grew up with medi
cin e. Th e yo un ges t of si x
children, with five older broth
ers, Nancy gain ed confidenc e
from her moth er' s ability to
combine medi cal practice with
a large fam il y. E ve n so, she
fee ls the progra m has helped
make he r fee l more at home
in medi ca l sc hoo l. Durin g
orientati on week, she allended
a bru nc h Cole organi zed for
women stu de nts and faculty.
Th e opportu nity to meet wom
en sci enti sts and physicians
on an in fo rma l bas is gave
Nancy an immedi ate sen se of
the profess ional c hoices
awa iting her upon graduation.
The Program fo r Women
in Science an d Medic ine

already goes well beyond giv
ing new wom en medi ca l stu
dents a warm welco me. Noon
luncheon talks on aspec ts o f
women's lives and wo rk in
sc ience and medi ci ne have
been well alle nded - with a
significant numbe r of inte r
es ted men in the audi ence.
All events are open to th e
entire medical sc hoo l co m
munity, and men are enco ur
aged to attend. Last October,
Profes sor Darlene Cl ark Hin e
of Mi chi gan State Uni ve rsity
opened a di stingui shed speak
ers ' se ri es with a lec ture on
the hi story of African -Ameri
can ph ys ician s, co-sponso red
with the Office of Min orit y
Affa irs. In March, the program
sponsored a half-day geneti cs
sy mposium at which out
standi ng women sci enti sts
from thi s sc hool and othe r
instituti ons di scu ssed their
resea rch. Nex t fall, Co ngress

~ilH'('

woman Patri cia Sc hroeder
(well-kn own fo r her work to
improve research on women's
health) will give the annu al
ke ynote address.
" Pat Co le has prov ided
out sta nding leade rship in
de vel oping thi s unique new
program," says Peck. The
leadership she prov ides is as
much by exampl e as by con
viction. Married to F. Sessions
Cole, professor of ped iatri cs
and of cel I bi o logy, and th e
mother of two yo un g daugh
ters, she carries both clini ca l
and admini strati ve res ponsi
biliti es. Enco uraged by the
achievements of the program's
first year, Col e notes, "The
immediate respon se sugges ts
it's a needed additi on that
enhances the edu cati onal
envi ronment not on ly for
women students and fac uity
but for the entire medica l
sc hoo l community."
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hile o n maneu ve rs
with the U.S . Army
in T e xas in 194 2,
lyin g on hi s back and lookin g
up at th e sta rs , Ri c hard A.
Sutter, M.D. '35 , dec ided th at
he wo uld not go into pri vate
practi ce as hi s fa ther had. A
year o f working with hi s uncle
in a SI. Loui s medical practice
a nd man y yea rs of watchin g
hi s fath e r provide ca re with 
out sendin g bill s to hi s patie nts
set Sutte r on a path to estab
lish an organi zatio n that woul.d
be pa id for th e services it pro
vided and wo uld al so do good
fo r the co mmunit y a nd espe
c ially fo r the wo rkin g man.
That decision was a fate ful
one , illustrati ve o f the idea
th at e very c hoice and eve ry
ac ti o n affec ts a hu ge ra nge of
peo ple and event s do wn
stream . Sutter we nt o n to
pioneer the practice of occu 
pati ona l medic ine in 51. Louis,
serving 1,500 St. Loui s bus i
nesses with health care fo r
e mployee s and ev e ntu a ll y
bringin g Barnes Hos pital
into the practi ce of occupa
tiona l m edicin e.
W he n he left the service,
Sutte r returned to Uni ve rsity
C ity - more than just a home
to wn to him , the or ig in al area
including what is no w "ni
versi ty C ity havi ng been
found ed as S utte r, MO, by
Ri c hard ' s great-great grand
fathe r, a pi o neer 1830 da iry
ma n w ho began wh at later
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Richard A. Slitter, M. D. '35, and his wife, Elizabeth Henby Sutter.
became the t. Loui s Dairy
C o. The post office fo r Sutter,
MO , was located o n wh at is
now O li ve Stree t Ro ad. Sutter
set o ut to inv es ti ga te hea lth
p rac ti ces in th e factori es of
the day . D uring 1936, a year
spent prac tic ing w ith his
uncle , Otto, Su tte r says he
had recognized that most
workme n lacked acce ss to
good hea lth care . Despite the
earli e r Wo rkme n' s C o mpe n
satio ll Ac t th at pro tected a
ma n' s j o b a nd benefits if he
w as injured in an acc ide nt ,
L

there was still m uc h to do.
M a ny diseases born o f expo 
sure to industrial agent s were
not recogn ized, and caps
we re pl aced on th e rei m
burseme nts an inju red worke r
could ex pect. Sutte r believed
that "t he working man is
en ti tled to the best care" and
ope ned th e Sutter Clinic to
provi de it.
Throug h his efforts, ma ny
St. Lou is compani es came to
rea li ze that th ey could save
m oney by inst ituting safety
prog rams to protect th e ir

wo rkers. Su tter al so fos tered
the re vo lutio nary co ncept of
ph ysic al examin atio ns pai d
for by e mploye rs, and he was
in strume ntal in ge ttin g occ u
pational medi c ine recog nized
as a leg itimate specialty, com
ple te wi th its own reg ulatory
board. Su tter and o the rs esta b
lished the M edi ca l-Denta l
Se rvice Bureau, forerun ne r to
Blu e C ross and Blue Shie ld.
When fe de ral offi c ials
workin g o n the O ccu pationa l
Sa fety and Health Act (OSHA)
sought an indepe nde nt. unbi

ased physician to advise them,
they ultimately chose Sutter.
For two terms, he served on
the National Advisory Com
mittee on Safety and Health
as the only physician. Sutter
contributed to OSHA's mod
ern approach of assisting
industry with safety measures
and training, helping to steer
the agency away from just
handing down fines to viola
tors of the act.
Closer to home, Sutter
advised commissioners of
occupational health in Mis
souri and was influential in
bringing forth state laws to
protect workers from lead
poisoning, silicosis, the
inhalation of hazardous gases
and chemicals and other
conditions. His dedication
to the field came at a time
when the definition of occu
pational medicine was chang
ing from including only
work-related accidents to
cover the many other types of
disability that result from
workplace exposure.
Timing was instrumental
in the success of the Sutter
Clinic, too. "Everybody else
was standing still, so we pret
ty much developed the prac
tice of occupational medicine
in Sl. Louis," Sutter says. He
remembers the occasion on
which he was called on a Sat
urday by the manager of the
then famous Forum Cafeteria
in downtown St. Louis, near
his offices. An employee had
deeply cut four fingers in an
automatic slaw cutter. Sutter
and his nurse responded,
spending many hours reposi
tioning the severed bones and
tendons so the unfortunate

patient might regain use of
the injured hand. The insur
ance company ' s agent on the
case was so impressed with
the degree of the patient's
recovery that Sutter's "name
went to the top of the list."
He remained the principal
surgeon for that major insur

employees was sold to Barnes
Hospital in 1984, changing
its name to Barnes/Sutter
Healthcare, a subsidiary of
the hospital.
The Sutters - a closely
knit team -were married
four days after Richard ' s
graduation from medical

Closer to home., Sutter advised
cOmImssioners of ocellJ.ationed
health in Missouri and was
influential in hringing fortL
state laws to proteetwnrkers
Iron1 lead pnis{)l1il1g~ silirosio.,
the inhalation of hazardous
gases and chenlieals and
ot.her conditions.
ance company for 30 years .
As a priority, Sutter main
tained his clinic ' s indepen
dence. It was never dependent
upon referrals and, in its 38
year history, accepted no
contracts, choosing instead to
be paid for work performed.
Sutter believes he was the
first Missouri physician to
incorporate and, on that score
as well as many others, always
enlisted the wise counsel of
his wife, Betty Henby Sutter.
The clinic that employed 10
physicians and 35 ancillary

school, the three days between
commencement and the nup
tials having been devoted to
state board examinations.
Richard and Betty had been
classmates as undergraduates
at Washington University ,
graduating in 1931. Togeth
er, they have raised three
children, two of whom remain
in St. Louis, while the third
resides in North Carolina.
Washington University
has always been an important
part of the Sutlers' lives:
Together they have served as

chairpersons of their class
reunions at every occasion
since their graduation. Richard
Sutter has also chaired each
reunion of his medical school
class since his graduation. He
is an original member of the
Eliot Society, holds member
ship number 0097 at Whitte
more House and originated
the class gift for the 50th year
reunion class. The Richard A.
and Betty H. Sutter Visiting
Professorship was established
in 1985 to bring an outstand
ing speaker on the subject of
occupational medicine to the
campus each year.
Today, the Sutlers enjoy
homes in Longboat Key, FL,
and in St. Louis. Successful
children and grandchildren
and interests in gol f, fishing
and travel keep them busy.
Sutter, who is mentioned
prominently in Who '5 Who In
America, currently advises
the directors of St. Mary's
Hospital in East St. Louis, IL,
on matters involving occupa
tional medicine, a new direc
tion for that hospital. The
couple continue to travel the
world and work for the bet
terment of the community.
In fact, Sutter seems clear
ly to have attained the two
life goals he set for himself:
to achieve a position that
allows his family to be free
from worry about the future
and to do something of mea
surable value for the commu
nity and especially the
working man.
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hen firth- graders
put on surgica l
g loves to ex plore
firsthand the lun gs of smokers
<lnd the livers of alco ho lics,
the impact is po we rful and
unforgettable. At least that's
the hope of medi ca l student s
who deliver the gross spec i
mens to the grade-sc hoo lers.
In fact, in their effort <It
drug education, th e first- and
second-year medic al stude nt s
do more than brin g a startlin g
object le sson to the c hi Idre n.
They run a comple te edu c<l 
tion progr<lm for the nine- and
IO-year-olds th<lt they hope
wi II steer the youn gs ters away
from substance abuse through
out their impression<lbl e years.
They bui Id the sel f-e stee m
th at tr<lnsl<ltes into resistance
to pee r press ure . And they
reac h the elementary sc hool
c hildre n at a cost per c hild of
less than one dollar.
Now in its second ye<lr,
the Washington University
Sc hool of Medicine Drug
Education Program is one of
a growing number of W<lYS in
whi ch programs funded by
the Alumni Association <It
Washington University School
of Medi cine reac h out to the
communit y. Headed up by
seco nd- year students Ashley
Hill , R<lY Lee <lnd Steven Wei,
the effo rt W<lS born as a col 
I<l borati on between students
and SI. Louis' Mariti. Corpo
rati on, which provided logis

W
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tical support during the pro
gram ' s first year o f 199 1.
Since it s incepti on. the stu
dents have set the program' s
direction. Armed with d<lta
that s<lY an estim <lted 70 per
cent of Missouri high sc hool
seniors use alcohol, <I tea m of
three medical students per
classroom (about 12 per event ,
since most elementary sc hoo ls
average four fifth- o r six th 
grade classroom s) visits the
youn gsters for two co nsec u
tive days. Each sess ion las ts
an hour <lnd 45 minutes.
On day one, the medi c<l l
students discuss with the chil
dren the effects of v<l ri ous
dru gs includin g mariju ana,

cocaine, ni cotine and alcohol.
Norma] gross s pec imens and
those from dru g users are
availab.le for the c hildren to
compare. No one misses the
point, Ashl ey Hill says. On
day two, time is spent in
games and exe rcises foc usin g
on self-estee m, dec ision-mak
ing skill s, ri sk a nd co nse
quence analys is and lea rnin g
to say " no."
Hill , who brought experi 
ence with de velopment al
psychology to the effort, says
the medic<ll students base
their <lppro<lch on the phil os
ophy that kids turn to dru gs
for <lny or <III of fi ve reasons:
I) They have no inform ati on

about the effec ts of drugs. 2)
They are poor dec ision mak
ers. 3) They succ umb to peer
press ure. 4) They can't deal
with their own moods and
seek an esca pe from stress.
5) They are adrift without
substantial goa ls. The pro
gr<lm work s to <lddress all of
those poss ibilities.
Durin g its first year, the
education prog ram reac hed
500 children in St. Loui s
schools. Thi s yea r, the hope
is to expand the effo rt to reach
as many as 1,700 more c hil 
dren in both city <l nd Park 
way schoo l di stri cts. Towa rd
that end , the medi ca l stude nts
appro<lc hed the exec uti ve

Students ill Ms. Lynn '5 sixth grade class at Ross Elementary School react strongly when asked
to compare Ilormal specimens with lungs from smokers and livers from alcoholics. Bringing
the object lesson to the children was second-year medical student Sabu Ch erian, a member of a
team of students embarked on a drug education program for area schoolchildren.

council of the medical school's
alumni association in August
with their request for funding.
In November, the alumni
association granted $1,350
for the program's operation
in 1992. The students pointed
out in their presentation that
their cost was less than a dol
lar per child, while the cost to
rehabilitate one adolescent in
a drug treatment center often
is several magnitudes greater.
They also might have men
tioned that fully one-third of
the second-year students
were active in the program' s
trial year.
Of the total grant, $350
wi II go to fund a survey of
pre- and post-course attitudes,
information and levels of
self-esteem. The remaining
$1,000 will pay for manuals,
training and materials. The
medical students wrote and
produced their own training
manual. "They 've done an
excellent job on their own,
and their work in prevention
is right on target ," says Collins
E. Lewis, M.D. , associate pro
fessor of psychiatry and
medical director of the Jewish
Hospilal Alcohol and Chemical
Dependency Program.
Though the education
program is designed primarily
to benefit the schoolchildren,
Hill acknowledges that the
opportunity for the medical
students to get out of class
and into an active, real-world
role has also been one of its
attractions. Performing a
service and taking action,
"makes everybody feel good,"
she says . •
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aul Hodges , M.D. '18,
is both fortunate and
fulfilled. Ninety-nine
years of good health have
been his blessing. And, in
nearly a century packed full
of living, he has maintained
the spirit to pursue experience
and wisdom at every turn.
Born just about the time
the School of Medicine was
being founded (when he cele
brates his personal centennial
on January 6, 1993, he wi II
miss the school's by just a
year and a few days), Hodges
left for a young man's adven
ture in China after graduating
from the University of Wis
cons in . In Shanghai, he
taught physiology and
planned his career as a physi
ologist. But Simon Flexner,
Rockefeller Institute director,
personally convinced Hodges
to attend Washington Univer
sity in pursuit of a medical
degree.
Whi Ie studying here,
Hodges says he "always had
to have a job," and recalls that
he was fortunate enough to
land a position as a student
assistant in the laboratory of
Joseph Erlanger, M.D. There,
he was party to ground brea k
ing work being done on the
replacement of fluids in shock.
The job paid additional
dividends. Part of Hodges'
assignment was to instruct
nursing students in physiology,
and in one of those classes he
met Merle Johnston , who lat
er became his wife . Together,

I:

,
I'

I

J
I"

I!
1[

Paul Hodges, M.D. '18, and his twin sister, Elizabeth Hodges
Moulton, celebrated their 99th birthdays in Green Bay, WI.,
earlier this year. Photograph courtesy of the Green Bay
Press-Gazette.
the couple raised five children,
two of whom survive.
Upon graduation from
medical school, Hodges went
back to China to work for the
China Medical Board of the
Rockefeller Foundation at
Peking Union Medical Col
lege. He stayed until 1927,
when he returned to this coun
try to become chief of radi
ology at the University of
Chicago. He served on the
faculty there for 31 years.

For many years, both he
and his brother, Fred J.
Hodges , II, chaired major
radiology departments.
Today, Paul's nephew , Fred
J. Hodges, III, M.D., is a
member of the faculty at the
medical school's Mallinck
rodt Institute of Radiology.
After Merle passed away,
retirement took Hodges to
Taiwan , where he remained
for three years until the Uni
versity of Florida called from
29
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halfway around the world in
March of 1964. Hodges signed
on th ere for what he thought
would be a few months, under
tak ing an assignment to re
establish the department of
radiology that had collapsed
at the death of its chairman.
He elected to serve as vi siti ng
professor and ended up stay
ing 17 years. After 14 years
of single life, he remarried
when Janet Reid , a talented
Florida watercolori st, agreed
to become hi s wife. The cou
pie li ved in Florida for 20
years, until Janet passed away
in 19 88.
Today, Hod ges lives in a
retirement home in Green
Bay. WI. where hi s twin sister
also resides. Thought to be the
senior alumnu s of the School
of Medic ine, he rema ins a full
professor emeritu s of two
universi ti es, a highly regard
ed man of medicine, a teac her,
a world traveler and a father
- nearl y a ce ntury of experi
ences clear in hi s memory .
Hi s biggest frustration is
th at declinin g heari ng and
sight have made it difficult
for him to ge t access to books
- the source of much of hi s
long life 's joy. Lately ,
though, new technology has
provided a video sc reen on
which printed words are
en larged 60 times, once again
mak in g read ing possible. Hi s
on ly compl aint about the
machine: "Too slow." That's
just the so rt of co mment a
man might make whose first
99 years of life have brought
him fulfillment but also have
keenly sharpened hi s appetite
for more .
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Roland W. Stuebner,
M.D. '23, writes that, at 94 ,
he has been a widower for
more than four years. He re
si des in a retirement home
outside of Seattle, where hi s
ge neral health remains exce l
lent. He reports that he takes
no medication, does not re
quire a doctor's care and only
regrets that macular degener
ati on is robbing him of his
vision. Stuebner is one of two
known surviving members of
the c lass of 1923.
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Reuben R. Harris, M.D.
'38, and hi s wife, Julia, cele
brated their 50th wedding
ann iversary on December
19. 199 1. The couple have
four children and nine grand
ch iIdren. Harri s has ret ired
after practicing medi ci ne for
50 yea rs.
Ewald W. Busse, M.D.
'42. is president and CEO of
the North Ca rolina In stitute
of Medi cine and dean emeri
tu s of the Duke University
School of Medicin e.
Benjamin S. Greenwood,
M.D. '43 (December), has
been in retirement for six
years. He writes of a trip to
Ru ss ia in 1989 that "Gorby"
was at the top of hi s form and
that the summer palace of
Peter the Great was "astound
ing and a credit to the art form
of a bygo ne era. "

Edwin G. Krebs, M.D.
'43 (December), a pioneer
in biochemi stry, has been
awarded the prestigious Robert
A. Welch Award in Chem
istry, recognizing hi s out
standing con tributions to the
field. Krebs is senior in vesti
gator emeritus for the Howard
Hu ghes Medical Institute and
professor in the Department
of Ph armacology at the Uni
versity of Washington at
Seattle. He shared the annual
award, given by the Texasbased Welch Foundation,
with Earl Reece Stadtman,
M.D .. of the Nationallnsti
tutes of Hea lth.
James c. Folsom, M.D.
'46, reports that he retired on
August 9,1991, and now
resides in Cedar Key, FL. He is
presently training to do Medi
care evaluations of psychi
atric fac ilities, a project he will
undertake on a part-time basis.
Russell D. Shelden, M.D.
'49. was honored with the
Di stin gui shed Service Award
by the University of Mi ssouri
- Columbia Alumni Associa
ti on on September 27, 1991.
In mid-October, Robert
C. Drews, M.D. '55, was
elected president of the Pan
America n Association of
Ophthalmology. With more
than 9,000 members in the
western hemisphere and sev
eral hundred affiliated mem
bers in the rest of the world,
it is by far the world's larges t
international organization in
ophthalmology.
Glendall King, M.D. '55,
reports that hi s wife , Lil a,
passed away on August 22,
1991 , and writes that, "She

was one of three wives who
started out with the medical
school class of 1955."
Philip Weinstein, Jr.,
M.D. '56, and hi s wife, Nan
cy, retired in 1991 and now
spend time travelling to visit
their children and grandchild.
He writes that they look for
ward to tennis, hobbies, more
travels and, perhaps, gol f.
Jerome F. Levy, M.D.
'58, has publi shed a book for
the genera l publi c titled. Your
Breasts (Farrar, Straus and
Giroux, Inc.).

60s and '70s
Dick D. Briggs, Jr., M.D.
'60, hold s the Eminent Schol
ar Chair of Respiratory Di sease at the University of
Alabama School of Medi 
ci ne. where he also se rves as
chairman of the Department
of Medicine. He is complet
ing hi s third year as preside nt
of the University of Alabama
Health Services Foundation
and has served as CEO dur
ing development and buildin g of the $125 million, l.M.
Pei-designed Kinklin Clinic
in the University of Alabama
Medical Center.
John H. Stone, III, M.D.
'62, has co-edited (with
Richard Reynold s, M.D.) On
Doctoring, published by
Simon and Schuster. The
book is an anthology of liter
ature concerning the practice
of medicine. The Robert
Wood Johnson Foundation
wi ll gi ve a copy to every
fres hman entering medical
school in the U.S. Th e gift

books will go out annually
for four yea rs - a total of
72,000 copies. The paper
back edition of Stone 's fourth
book, In The Country Of
Hea rts, was released in
February 1992.
Jeannie Kinzie, M.D.
'65, writes that she married
Johnson Wachira in Nairobi ,
Kenya on October 7, 1991.
She hopes to work as a physi
cian in East Africa and, in the
company of her husband,
climb the great mountains of
the world . Both are accom
pli shed mountaineers.

Miclwel R. Treister, M.D. '67.
Micbael Roy Treister,
M.D. '67 , was recently elect
ed president of C hicago's
Jewish Vocational Se rvice.
Treister now heads the public
service agency that last year
helped 15.000 res ide nts of
metropoli ta n C hicago, includ
ing many Russ ian immigrants,
to find jobs, train in new
skills and learn to live inde
pendently in the community.
Bruce D. Fisher, M .D.
'70, has been promoted to
clinical professor of medici ne
and dent istry at Robert Wood

Johnson Medical School of
the University of Medicine
and Denti stry of New Jersey
in New BrunswicklPi scat
away, NJ.
John Eisenberg, M.D.
'72, reports hi s move to
Washington , DC, where he
has been appointed to the
post of chairman of the
Department of Medicine
at Georgetown Univers ity
Medical Center.
Donald R. Graham,
M.D. '74, serves as chief of
infectiou s diseases at the
Springfield Clinic in Spring
field, IL. He and his wife cel
ebrated the birth of their sixth
child, Edith, in 1990.
Pamela G allin, M.D. ' 78,
was among the doctors named
in the November 11 cover
story of New York magazine
titled "The Best Doctors in
Ne w York. " An ophthalmol
ogist affiliated with Col umbia
Presbyterian Medical Center
in Manhattan , Gallin was
honored for her work with
strabismus. Nominations to tal
ling 11,000 were narrowed to
1,085 doctor" on the final list.
R llbert D. R osenber g,
M.D. '79, has been promoted
to the position of associate
professor of radiology and
recently celebrated the birth
of his seco nd child. Leah.

"80s
Hen ry F. Sadovsky, M.D.
' 8 1, has joined the Depart
ment of Internal Med icine/Car
diology at Group Hea lth ,
Inc. 's Riverside Medical
enter in Minneapolis.

Jeffrey Stein, M .D. '82,
practices vascular surgery at
Mount Sinai Med ica l Center
in New York and began a pri
vate practice in July 1990.
Daryl L. Jacobs, M.D.
'83, FA.C.C., has been elect
ed to fellowship in the Amer
ican College of Cardiology.
Jacobs is in the private prac
tice of cardiology with Cardi
ology Consultants, Ltd. , in
SI. Louis.
Jonath a n W . J a ntz,
M.D, '83, reports that he
was married to the former
Sue Ann Goossen - an
attorney in Ne wton , KS 
on June 8,1991.
David L ubarsky, M .D.
'84. the first graduate of the
Was hington University
School of Medicine ' s Schol
ars' Program in Medicine, is
currently an assistant profes
sor of anesthesiology at Duke
University and was promoted
in July to the position of
chief of the section of vascu
lar and thorac ic anesthesia.
Together with Chris Gal
lagher, M.D. '84, he wrote
the book , P reparing for the
Anesthesia Orals - Board
Stiff, that has become a
favorite in th e fie ld or anes
thesiology. O n a more per
sonal note. he reports that he
was married in Ju ne of 1990
and th at he and his wife , Cin
di, ce lebrated the birth of
their son, Isaac Daniel, on
September 6, 1991 .
Dianne H. Levisohn ,
M.D. '85, was one of 12 fac
ulty members at the Universi
ty of New Mexico School of
Medicine to receive Fac ulty
Excellence in Teaching
Awards for 1990- ' 91. Based

on her contribution to medi
cal education in New Mexi
co, Levisohn was named a
second-place winn er from the
departm ent of dermatology
for her postgraduate clini ca l
teaching.
Michelle Butzer Ruby,
M .D. '86, lives in Portland,
OR and works as a pediatri
cian for Kaiser Permanente
Group. Her husband , Mar
shall , is also employed by
Kaiser a~ a ped iatric denti st.
The coupl e have a "wonder
ful" daughter, Juli a Rose,
born in October of 1990.
Eric E. Stevens, M.D.
'86. is currently a second
year fellow in pulmonary
critical care medicine at th e
University of Colorado Health
Science Cen te r in Denver.
W illiam L. Becker, M.D.
'87, was married on June 2,
1990. He completed his train
ing and joined the St. Louis
Eye C linic in Ju ly 1991.
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Robert Maltz, M.D., F.H.s.
in otolaryngology , has been
elected to the Board of Gov
e rnors of the University of
C incinnati A lumni Assoc ia
tion and appointed to the
Executi ve C ou ncil of the
University of C incinnati Col
lege of Medicine.
Jobn D. Ha lverson, M.D.,
F.H.S. in surgery , has been
appointed professor of
surgery, vice chairman of the
Department of S urgery and
chief of the division of gener
al surgery at SUNY, S yra
cuse.
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Mary A. Alexander, NU

.1

'48, Ed.D., plan s to retire
from the faculty of the Ari
zona College of Nursing in
June 1992. She has worked
recently in China as a consul
tant for the World Health
Orga nization. In 1989, she
rece ived the Nurse of the Year
Award from the Arizona
Nurses' Assoc iation and in
J99 1 received the Award of
Di stinction for Excellence in
Nurs ing Education from Sig
ma Theta Tau International
Nurs ing Society.

Joanne Parrott, NU '50,
has been appointed to the
Board of Directors of the
Auxiliary to the American
Dental Association. She
assumes the chair of the Den
tal Hea lth Education Com
mittee on which she served
last year.

Geneva F. Newman, NU
.1

'69, has retired and now vol
unteers with the literacy
council in her home state of
Arkansas.
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Max Deutch, M.D. '26,

Robert R. Kulesher, HA '77
Robert R. Kulesher, HA
'77, has been appointed to
the post of administrator of
the St. Francis Country House
in Darby , PA, a 273-bed
facility established in 19 J 3.
Kul eshe r is on the faculty at
Penn State University'S School
of Hea lth and Human Devel
opment and at Saint Joseph 's
University'S graduate schoo l,
De partment of Education a nd
Hea lth Services.

Linda Birkinbine, O.T.
'90, writes that s he enjoys
" being an O. T. in the eastern
part of North Carolina. I work
with patients with spinal cord
injuries and would love to
hear from my classmates who
graduated in ' 90." Phone
(919) 355-3705.

rece ntly honored for hi s 50
years of serv ice to St. Louis
Children's Hosp ital, died
January I, 1992, following a
brief illness. Deutch retired
from pri vate practice in 1965
but continued to work part
time as a pediatrician in St.
Louis· well-baby clinics,
county schoo l di stricts, at the
Mi ssouri School for the Blind
and at city and county health
departments.

T. Eugene Rull, M.D. '38,
passed away March 25 , 1991.

Robert S. Weinhaus, M.D.
'45 , succumbed to compl.ica
tions from a liver tran sp lant
on December 31, 1991, at
Presbyterian University Hos
pital in Pittsburgh , PA . Wein
ha us practiced internal
medicine until a back injury
curtailed hi s work; he then
co mpleted a psychiatry resi
dency and became a board
certi fied psychiatrist.

Roy O. Kelly, Jr., M.D.
'53, died October 22, 199 I,
in Shawnee , OK.

Leonard J. Tolmach

Ph.D., professor emeritu~ of
radiation biology, died Tues
day , November 26, 1991, at
the age of 68. He succumbed
to cancer. Tolmach worked
for more than 30 year at the
medical schoo l's Mallinck
rodt In stitute of Radiology,
where he investigated the
mechani s m by which radia
tion kills cancer cells. An
inventor and a hi g hly regard
ed contributor to th e field of
radiation research , Tol mach
often claimed to be "j us t
an average, hard-working sc i
entist. There are thou sands
of them; every univers ity' s
full of them." In fact, he
was "anything but average,"
according to Ronald G. Evens,
M.D., director of Mallinck
rodt In stitute, who says,
"Profes sor Tolmac h received
not only some of the nation 's
hi ghest honors in radiation re
searc h but also the admiration
of his colleagues and peers."
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'57 , '62, '67, '72, '77 , '82
Register now - join yo ur
classmates at Reunion '92.
May 7,8,9
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The alumlti associatioll has funded a drug educatiolt program designed and operated by second
year medical students. Fifth- and sixth-graders in two area school districts encounter the direct
effects of drug use and abuse when medical students like Ashley Hill briltg gross specimens ill to
the elementary school classroom. For more on the program, see page 28 of this issue.

